Article: NAD+ Levels Control Inflammatory Responses in Immune Cells: Preclinical Findings

PrevNext
Immune Health Inflammation Preclinical

NAD+ Levels Control Inflammatory Responses in Immune Cells: Preclinical Findings

Synopsis

NAD+ is important for cell metabolism and inflammation, but how it affects immune cells is not well understood. This study looked at how changing NAD+ levels using nicotinamide riboside (NR) or an inhibitor affects inflammation in human monocytes. When NAD+ was increased, the cells released more of the inflammatory molecule IL-1β after stimulation. Lowering NAD+ blocked inflammation signals, especially through the TLR4 pathway, without involving certain enzymes called sirtuins or PARP1. This shows NAD+ plays a new role in controlling inflammation, which is important for considering NR as a treatment for inflammatory diseases.

Journal

The Journal of Immunology

Share

Read more

Neurological Health

Nicotinamide Ribosides Improves Aerobic Performance: Preclinical Findings

Synopsis Nicotinamide riboside (NR) is a form of vitamin B3 that helps increase NAD+ and improve mitochondrial function, but its effect on physical fitness is unclear. In a study with sedentary an...

Read more
Liver Health

Nicotinamide Riboside Protects Against Diet-Induced Liver Injury: Preclinical Findings

Synopsis Nicotinamide riboside (NR), a precursor to NAD+, helps prevent metabolic and age-related disorders in mice, but the role of naturally occurring NR metabolism is less understood. Researche...

Read more